Beneficial effect of eucommia polysaccharides on systemic lupus erythematosus-like syndrome induced by campylobacter jejuni in BALB/c mice

Inflammation

Volumn 34, Issue 5, 2011, Pages 402-411

  Jiang, Long ^a   Wang, Zheng ^a   Zhu, Hong Wei ^a   Di, Hong Ye ^a   Li, Hong ^a   Zhang, Yun Yi ^a   Chen, Dao Feng ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Autoantibody; Autoimmunity; Campylobacter jejuni; Eucommia ulmoides; Polysaccharides; Systemic lupus erythematosus (SLE)

Indexed keywords

IMMUNOGLOBULIN; POLYSACCHARIDE; PREDNISONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; CAMPYLOBACTER JEJUNI; COMPLEMENT INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG ISOLATION; DRUG MECHANISM; EUCOMMIACEAE; FEMALE; GLOMERULONEPHRITIS; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN DEPOSITION; IMMUNOGLOBULIN PRODUCTION; LUPUS LIKE SYNDROME; MOUSE; NONHUMAN; PLANT STEM; PROTEINURIA; RENAL PROTECTION; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT DURATION; TREATMENT RESPONSE; TU CHUNG;

ANIMALS; AUTOANTIBODIES; CAMPYLOBACTER JEJUNI; COMPLEMENT INACTIVATING AGENTS; DISEASE MODELS, ANIMAL; EUCOMMIACEAE; FEMALE; IMMUNOGLOBULIN G; KIDNEY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MEDICINE, CHINESE TRADITIONAL; MICE; MICE, INBRED BALB C; PHYTOTHERAPY; PLANT BARK; POLYSACCHARIDES; SYNDROME;

CAMPYLOBACTER JEJUNI; EUCOMMIA; EUCOMMIA ULMOIDES; MUS;

EID: 80655141827     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-010-9247-7     Document Type: Article

References (42)

1. Sturfelt, G. 2002. The complement system in systemic lupus erythematosus. Scandinavian Journal of Rheumatology 31: 129-132. (Pubitemid 34713075)
2. WZ. Xie, C.S. Fan, Z.YZhu, editors. 1996. Quan Guo Zhong Cao Yao Hui Bian. Beijing: People's Medical Publishing House. pp. 423-424.
3. Ge, J.R., H.M. Wang, L.Z. Yang, H.B. Yin, X.H. Feng, Q. Jiang, et al. 2002. II Period clinical trial of compound Du Zhong Jian Gu Grain treating knee osteoarthritis. Chin J Trad Med Traum & Orthop 10: 19-23
4. Jiangsu New Medical College. 1977.Dictionaryof Chinese Herbal Medicine, vol. 1, 1031-1033. Shangha: Shanghai Science and Technology Publishing House.
5. Deyama, T., S. Nishibe, and Y Nakazawa. 2001. Constituents and pharmacological effects of Eucommia and Siberian ginseng. Acta Pharmacologica Sinica 22: 1057-1070.
6. Tomada, M., R. Gonda, N. Shimizu, and M. Kanari. 1990. A reticuloendothelial system-activating glycan from the barks of Eucommia ulmoides. Phytochemistry 29: 3091-3094.
7. Xu, S.L., H.Q. Zhou, WG. Huang, Q.Z. Zeng, M. Liu, and Z.X. Pan. 1983. Influences of Eucommia ulmoides on nonspecific immunity oforgans. Chin Tradit Herb Drugs 14: 27-28.
8. Abe, M. 2006. Complement activation and inflammation. Rinsho Byori 54: 744-756.
9. Sahu, A., and J.D. Lambris. 2000. Complement inhibitors: A resurgent concept in anti-inflammatory therapeutics. Immunophar-macology 49: 133-148. (Pubitemid 30445225)
10. Sarma, VJ., M. Huber-Lang, and PA. Ward. 2006. Complement in lung disease. Autoimmunity 39: 387-394. (Pubitemid 44269616)
11. Oshima, Y, S. Takata, H. Hikino, T. Deyama, and G. Kinoshita. 1988. Anticomplementary activity of the constituents of Eucommia ulmoides bark. Journal of Ethnopharmacology 23: 159-164.
12. Zhou, J., Y.Y. Zhang, J.W Zhang, H. Xu, and D.F. Chen. 2006. Research in Chinese traditional medicine Eucommia ulmoides Oliver of the effect on complement system. Journal of Fudan University (Med Sci) 33: 101-106. (Pubitemid 43357211)
13. Zhu, H.W, Y.Y. Zhang, J.W Zhang, and D.F. Chen. 2008. Isolation and characterization of an anti-complementary protein-bound polysaccharide from the stem barks of Eucommia ulmoides. International Immunopharmacology 8: 1222-1230.
14. Zhu, H.W, H.Y. Di, Y.Y. Zhang, J.W Zhang, and D.F. Chen. 2009. A protein-bound polysaccharide from the stem barks of Eucommia ulmoides and its anti-complementary effect. Carbohydrate Research 344: 1319-1324.
15. Wang, Z., H. Li, H. Xu, X.L. Yue, X.Q. Cheng, WJ. Hou, Y.Y.Zhang, and D.F. Chen. 2009. Beneficial effect of Bupleurum polysaccharides on autoimmune disease induced by Campylobacterjejuni in BALB/c mice. Journal of Ethnopharmacology 124: 481-487.
16. Xiao, Z.Y, Q.Y Zheng, J.P Zhang, Y.Y. Jiang, and YH. Yi. 2002. Effect ofesculentoside A on autoimmunity in mice and its possible mechanisms. Acta Pharmacologica Sinica 23: 638-644.
17. Zhou, L.L., W Wei, YX. Shen, and S.Y. Xu. 2002. The effects of TGP on CJ-S131 induced systemic lupus erythematosus-like model in mice. Chin Pharmacol Bull 18: 175-177. (Pubitemid 34456454)
18. Dubois, M., K.A. Gilles, J.K. Hamilton, PA. Rebers, and F. Smith. 1956. Colorimetric method for determination of sugar and related substances. Analytical Chemistry 28: 350-356.
19. Blumenkr, N., and G. Asboehan. 1973. New method for quantitative determination of uronic acids. Analytical Biochemistry 54: 484-489.
20. Li, H., Y.Y. Zhang, YN. Sun, X.Y. Huang, Y.F. Jia, and D. Li. 2004. Induction of systemic lupus erythematosus (SLE) syndrome in BALB/c mice by immunization with active chromatin. Acta Pharmacologica Sinica 25: 807-811. (Pubitemid 38736109)
21. Ma, A., H. Wu, and P Zhang. 2000. Induction of anti-nuclear antibodies and systemic lupus erythematosus (SLE)-like syndrome by immunization with active DNA. Chinese Journal of Rheuma-tology 4: 15-18.
22. Nicoletti, F., R. Di Marco, P. Zaccone, M. Xiang, G. Magro, S. Grasso, S. Morrone, A. Santoni, Y Shoenfeld, G. Garotta, and P Meroni. 2000. Dichotomic effects of IFN-gamma on the develop-ment of systemic lupus erythematosus-like syndrome in MRL-lpr/ lpr mice. European Journal of Immunology 30: 438-447. (Pubitemid 30098836)
23. Rangan, G.K., and G.H. Tesch. 2007. Quantification of renal pathology by image analysis. Journal of Nephrology 12: 553-558.
24. Tzianabos, A.O. 2000. Polysaccharide immunomodulators as therapeutic agents: structural aspects and biological function. Clinical Microbiology Reviews 13: 523-533.
25. Paulsen, B.S. 2001. Plant polysaccharides with immunostimulatory activities. Current Organic Chemistry 5: 939-950. (Pubitemid 33069423)
26. Wasser, S.P 2002. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Applied Microbiology and Biotechnology 60: 258-274.
27. Chihara, G. 1992. Recent progress in immunopharmacology and therapeutic effects of polysaccharides. Developments in Biological Standardization 77: 191-197.
28. Wang, S.Y, M.L. Hsu, H.C. Hsu, C.H. Tzeng, S.S. Lee, M.S. Shiao, and C.K. Ho. 1997. The antitumor effect of Ganoderma lucidum is mediated by cytokines released from activated macro-phages and T lymphocytes. International Journal of Cancer 70: 699-705.
29. Sergeev, A.V, E.S. Revazova, S.I. Denisova, O.V Kalatskaia, and A.N. Rytenko. 1985. Immunomodulating and antitumor activity of polysaccharides of plant origin. Bulletin Experimental Biology Medicine 100: 741-743. (Pubitemid 16193353)
30. Lazareva, E.B., T.G. Spiridonova, E.N. Chernega, L.G. Plesskaia, I.V Grunenkova, S.V Smirnov, et al. 2002. Topical pectins for the treatment of burn wounds. Antibiotiki i Khimioterapiia 47: 9-13. (Pubitemid 135748143)
31. Gan, O.I., N.I. Drize, S. Gola, S. Shrum, and R. Net. 1991. Effects of polysaccharide from Thuja occidentale L. on stromal precursor cells of hematopoietic microenvironment in mice. Bulletin Exper-imental Biology Medicine 112: 635-637.
32. Liu, S. 1991. Radiosensitivity of marrow stromal cells and the effect of some radioprotective agents. Acta Acad Med Sin 13: 338-342.
33. Narimanov, A.A., O.I. Popova, and D.A. Murav'eva. 1992. Changes in the sensitivity of mice to the action of gamma irradiation by Viscum album L. polysaccharides. Radiobiologiia 32: 868-872.
34. Schepetkin, I.A., and M.T. Quinn. 2006. Botanical polysacchar-ides: macrophage immunomodulation and therapeutic potential. International Immunopharmacology 6: 317-333. (Pubitemid 43120446)
35. Li, H., Y.Y. Zhang, X.Y Huang, YN. Sun, YF. Jia, and D. Li. 2005. Beneficial effect of tripterine on systemic lupus erythema-tosus induced by active chromatin in BALB/c mice. European Journal of Pharmacology 512: 231-237. (Pubitemid 40544358)
36. Hu, J.G., A. Ide, T. Yokoyama, and T. Kitagawa. 1989. Studies on the optimal immunization schedule of the mouse as an exper-imental animal-the effect of antigen dose and adjuvant type. Chemical & Pharmaceutical Bulletin 37: 3042-3046. (Pubitemid 20056086)
37. Valentijn, R.M., H. vanoverhagen, H.M. Hazevoet, J. Hermans, A. Cats, M.R. Daha, et al. 1985. The value of complement and immune complex determinations in monitoring disease activity in patients with systemic lupus erythematosus. Arth Rheum/Ar C Res 28: 904-913. (Pubitemid 15021485)
38. Nasiri, S., M. Karimifar, Z.S. Bonakdar, and M. Salesi. 2009. Correlation of ESR, C3, C4, anti-DNA and lupus activity based on British Isles Lupus Assessment Group Index in patients of rheumatology clinic. Rheumatology International. doi:10.1007/ s00296-009-1201-3.
39. Liu, C.C., N. Danchenko, J.S. Navratil, S.E. Nilson, S. Manzi, and J.M. Ahearn. 2005. Mining the complement system for lupus biomarkers. Clin App Immunol Rev5: 185-206. (Pubitemid 40823850)
40. Chen, X.Q., H. Li, X.L. Yue, J.Y. Xie, Y.Y. Zhang, H.Y. Di, and D.F. Chen. 2010. Macrophage immunomodulatory activity of the polysaccharides from the roots of Bupleurum smithii var. parvifo-lium. Journal of Ethnopharmacology 130: 363-368.
41. Katsiari, C.G., S.N. Liossis, and P.P. Sfikakis. 2010. The pathophysiologic role of monocytes and macrophages in systemic lupus erythematosus: a reappraisal. Seminars in Arthritis and Rheumatism 39: 491-503.
42. Aringer, M., and J.S. Smolen. 2005. Cytokine expression in lupus kidneys. Lupus 14: 13-18. (Pubitemid 40216062)